Cargando…

Evaluation of triple negative breast cancer with heterogeneous immune infiltration

INTRODUCTION: Tumor infiltrating lymphocytes (TILs) are known to be a prognostic and predictive biomarker in breast cancer, particularly in triple negative breast cancer (TNBC) patients. International guidelines have been proposed to evaluate them in the clinical setting as a continuous variable, wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quintana, Ángela, Arenas, Enrique Javier, Bernadó, Cristina, Navarro, José Fernández, González, Jonatan, Esteve-Codina, Anna, Moliné, Teresa, Marti, Merce, Curigliano, Giuseppe, Schmid, Peter, Peg, Vicente, Arribas, Joaquín, Cortés, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196631/ https://www.ncbi.nlm.nih.gov/pubmed/37215143 http://dx.doi.org/10.3389/fimmu.2023.1149747

Ejemplares similares

Epstein–Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report
por: Aran, Andrea, et al.
Publicado: (2021)

Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response
por: Aran, Andrea, et al.
Publicado: (2023)

Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
por: Aran, Andrea, et al.
Publicado: (2022)

Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
por: Duro-Sánchez, Santiago, et al.
Publicado: (2022)

The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1
por: Nadal-Serrano, Mercedes, et al.
Publicado: (2020)

Immunotherapy for early triple negative breast cancer: research agenda for the next decade
por: Tarantino, Paolo, et al.
Publicado: (2022)

Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts
por: Morancho, Beatriz, et al.
Publicado: (2016)

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
por: Marra, Antonio, et al.
Publicado: (2020)

Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer
por: Yuan, Yinyin
Publicado: (2015)

Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

The Cornella Health Interview Survey Follow-Up (CHIS.FU) Study: design, methods, and response rate
por: Garcia, Montse, et al.
Publicado: (2003)

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
por: Hergueta-Redondo, Marta, et al.
Publicado: (2016)

peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
por: Martínez‐Sáez, Elena, et al.
Publicado: (2016)

Beyond molecular tumor heterogeneity: protein synthesis takes control
por: Ramon y Cajal, Santiago, et al.
Publicado: (2018)

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies
por: Vicario, Rocio, et al.
Publicado: (2015)

Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice
por: Martínez-Sabadell, Alex, et al.
Publicado: (2022)

Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Herrero-Vicent, Carmen, et al.
Publicado: (2017)

Low Complexity Induces Structure in Protein Regions Predicted as Intrinsically Disordered
por: Gonçalves-Kulik, Mariane, et al.
Publicado: (2022)

High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy
por: Nuciforo, Paolo, et al.
Publicado: (2015)

Gene expression‐based classifications of fibroadenomas and phyllodes tumours of the breast
por: Vidal, Maria, et al.
Publicado: (2015)

Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019)

Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization
por: Gomez-Macias, Gabriela Sofia, et al.
Publicado: (2020)

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
por: Smith, Alison E., et al.
Publicado: (2021)

ProtSA: a web application for calculating sequence specific protein solvent accessibilities in the unfolded ensemble
por: Estrada, Jorge, et al.
Publicado: (2009)

Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer
por: Kilmartin, Darren, et al.
Publicado: (2021)

Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
por: Brasó-Maristany, Fara, et al.
Publicado: (2021)

The sequence context in poly-alanine regions: structure, function and conservation
por: Mier, Pablo, et al.
Publicado: (2022)

Trends in practical applications of heterogeneous multi-agent systems : the PAAMS collection
por: Perez, Javier, et al.
Publicado: (2014)

Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021()
por: Trapani, Dario, et al.
Publicado: (2021)

Heterogeneity of cytotoxic T cell infiltration in breast and colorectal cancer
por: Ziai, James, et al.
Publicado: (2015)

Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration
por: Wang, Zeya, et al.
Publicado: (2018)

Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues
por: Giovannini, Diane, et al.
Publicado: (2023)

Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
por: Lejeune, Marylène, et al.
Publicado: (2023)

Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
por: Čeprnja, Toni, et al.
Publicado: (2022)

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
por: Gorenšek, Rok, et al.
Publicado: (2023)

Investigating the Formation of Structural Elements in Proteins Using Local Sequence-Dependent Information and a Heuristic Search Algorithm
por: Estaña, Alejandro, et al.
Publicado: (2019)

Functional and molecular heterogeneity of D2R neurons along dorsal ventral axis in the striatum
por: Puighermanal, Emma, et al.
Publicado: (2020)

Triple función /
por: Blanco, José Joaquín, 1951-
Publicado: (2007)

Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment
por: Valenza, Carmine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jgkneamvadq32r4mht2n0618l4